NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.68% |
LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 2.54% |
NVAX | Novavax Inc | Healthcare | Biotechnology | 2.12% |
GERN | Geron Corporation | Healthcare | Biotechnology | 1.84% |
XERS | Xeris Pharmaceuticals Inc | Healthcare | Biotechnology | 1.84% |
6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 1.81% |
MORF | Morphic Holding Inc | Healthcare | Biotechnology | 1.74% |
AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 1.64% |
LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 1.62% |
ANAB | AnaptysBio Inc | Healthcare | Biotechnology | 1.50% |
ARQT | Arcutis Biotherapeutics Inc | Healthcare | Biotechnology | 1.50% |
PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 1.43% |
MLYS | Mineralys Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | 1.40% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.29% |
KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 1.28% |
BLTE | Belite Bio Inc ADR | Healthcare | Biotechnology | 1.26% |
NK | NantKwest Inc | Healthcare | Biotechnology | 1.23% |
TKM | Arbutus Biopharma Corp | Other | Other | 1.20% |
MRUS | Merus BV | Healthcare | Biotechnology | 1.18% |
OMER | Omeros Corporation | Healthcare | Biotechnology | 1.14% |